Fingerprint
Dive into the research topics of 'First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer
C Massard, A Azaro, J-C Soria, U Lassen, C Le Tourneau, D Sarker, C Smith, U Ohnmacht, G Oakley, B K R Patel, E S M Yuen, K A Benhadji, J Rodon